Related Experiment Video
Updated: Jun 24, 2026
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Characterization and expression of extrahepatic CYP2S1
Subrata Deb1, Stelvio M Bandiera
1University of British Columbia, Faculty of Pharmaceutical Sciences, 2146 East Mall, Vancouver, British Columbia, V6T 1Z3, Canada.
Expert Opinion on Drug Metabolism & Toxicology
|April 17, 2009
Summary
The cytochrome P450 2S1 (CYP2S1) enzyme has a unique expression pattern across tissues. Further research is required to understand its role in xenobiotic metabolism and disease.
Area of Science:
- Biochemistry
- Pharmacology
- Genetics
Background:
- The cytochrome P450 (CYP) enzyme family includes numerous members, with approximately one-third belonging to the CYP2 subfamily.
- Novel CYP enzymes, such as CYP2S1, CYP2U1, and CYP2W1, are part of this family.
- Limited data exists on the catalytic activity and function of CYP2S1.
Purpose of the Study:
- To compare messenger RNA (mRNA) and protein expression of CYP2S1 in humans, mice, and rats.
- To critically evaluate existing evidence on CYP2S1 regulation.
- To examine the catalytic activity of CYP2S1.
Main Methods:
- Literature review of published reports on mouse and human CYP2S1.
- Analysis of recent author data on rat CYP2S1 expression.
Main Results:
- CYP2S1 exhibits distinct tissue expression profiles.
- Molecular characteristics suggest CYP2S1 aligns with both CYP1 and CYP2 families.
Conclusions:
- CYP2S1 displays unique tissue distribution.
- Further studies are necessary to identify specific substrates and quantify CYP2S1 protein levels.
- The precise role of CYP2S1 in xenobiotic metabolism, physiological pathways, and disease requires further investigation.
Related Concept Videos
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:14Hepatic Drug Clearance: Role of Transporters
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...